Clinical Advances

In the Management of Generalized Pustular Psoriasis

CME Activities

How Would You Manage This Patient With Generalized Pustular Psoriasis?

Medscape Education, November 2022

Did you know that 1 in 5 people suffering from generalized pustular psoriasis (GPP) have severe complications?
New Frontiers in Neutrophilic Dermatoses: Role of the IL-36 Pathway

Medscape Education, October 2022

Did you know that deregulation of the interleukin-36 (IL-36) pathway underlies several skin conditions? Learn which ones and the implications for therapeutic options.
New Horizons in Managing Generalized Pustular Psoriasis

Medscape Education, September 2022

Are you up to date with understanding the pathogenesis of generalized pustular psoriasis (GPP) and how to best optimize use of current therapies?

1.00 CME
Countdown to Knowledge of Novel Therapies for Generalized Pustular Psoriasis Flares

Medscape Education, June 2022

Did you know that the severity of generalized pustular psoriasis (GPP) can be so great that up to 30% of the body surface area can be involved in up to one-third of patients?

0.25 CME
Can You Diagnose This Patient With Skin Pustules?

Medscape Education, May 2022

Did you know that flare recurrence is a hallmark of certain rarer forms of pustular psoriasis?

0.25 CME

Advances in GPP

Management of Patients With GPP – Understanding the Disease

Resources

Downloadable Slide Kit

Clinical Advances in the Management of Generalized Pustular Psoriasi

Clinical Articles

Steering Committee

Jonathan Barker, MD

Steering Committee Chair

Professor of Medical Dermatology
Head, St. John's Institute of Dermatology
London, United Kingdom

Bio Video

Kilian Eyerich, MD, PhD

Professor of Dermatology & Immunology
Karolinska Institute
Stockholm, Sweden

Bio Video

Abby Van Voorhees, MD

Professor and Chair
Department of Dermatology
Eastern Virginia Medical School
Norfolk, Virginia, United States

Bio Video

Mark G. Lebwohl, MD

Professor and Waldman Chair
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Bio Video

Herve Bachelez, MD, PhD

Professor
Hopital Saint-Louis Sorbonne
Paris Diderot University
Paris, France

Bio Video

Siew Eng Choon, FRCP

Associate Professor
Clinical School Johor Bahru
Jeffrey Cheah School of Medicine and Health Sciences
Monash University Malaysia
Consultant Dermatologist
Hospital Sultanah Aminah Johor Bahru
Johor, Malaysia

Bio Video

Steering Committee

Jonathan Barker, MD

Steering Committee Chair

Has disclosed the following financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; Almirall Hermal GmbH; Amgen Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Eli Lilly and Company; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Samsung; Sun Pharmaceutical Industries, Ltd.; UCB Pharma, Inc.

Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Almirall Hermal GmbH; Amgen Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Eli Lilly and Company; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Samsung; Sun Pharmaceutical Industries, Ltd.; UCB Pharma, Inc.

Received grants for clinical research from: AbbVie Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Janssen Pharmaceuticals; LEO Pharma; Novartis Pharmaceuticals Corporation; UCB Pharma, Inc.

Other: Independent contractor for: AbbVie Inc.; Almirall Hermal GmbH; Amgen Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Eli Lilly and Company; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Samsung; Sun Pharmaceutical Industries, Ltd.; UCB Pharma, Inc.

Kilian Eyerich, MD, PhD

Steering Committee Member

Has disclosed the following financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Galderma Laboratories, L.P.; Janssen Pharmaceuticals; Leo Pharma; Novartis Pharmaceuticals Corporation; Pfizer Inc.; UCB Pharma, Inc.; Sanofi

Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Galderma Laboratories, L.P.; Janssen Pharmaceuticals; Leo Pharma; Novartis Pharmaceuticals Corporation; Pfizer Inc.; UCB Pharma, Inc.; Sanofi

Received grants for clinical research from: AbbVie Inc.; Eli Lilly and Company; Galapagos; Janssen Pharmaceuticals; Leo Pharma; UCB Pharma, Inc.

Abby Van Voorhees, MD

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: Amgen Inc.; Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; UCB Pharma, Inc.

Received grants for clinical research from: AbbVie Inc.; Novartis Pharmaceuticals Corporation

Other: Independent contractor for: AbbVie Inc.; Novartis Pharmaceuticals Corporation

Mark G. Lebwohl, MD

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: Aditum Bio; Almirall Hermal GmbH; AltruBio Inc.; AnaptysBio; Arcutis Inc.; Arena Pharmaceuticals, Inc.; Aristea Therapeutics; Arrive Techonologies; Avotres Therapeutics; BiomX; Boehringer Ingelheim Pharmaceuticals, Inc.; Brickell Biosciences; Corevitas; Dermavant Sciences; Dr. Reddy's Laboratories; Evelo Biosciences; Evommune Inc.; Forte Biosciences; Helsinn Therapeutics, Inc Therapeutics; Hexima Ltd.; Leo Pharma; Meiji Seika Pharma; Mindera; Pfizer Inc.; Seanergy; Verrica

Received grants for clinical research from: AbbVie Inc.; Amgen Inc.; Arcutis; Avotres; Boehringer Ingelheim Pharmaceuticals, Inc.; Cara Therapeutics; Dermavant Sciences; Eli Lilly and Company; Incyte Corporation; Janssen Pharmaceuticals; Ortho Dermatologics; Regeneron Pharmaceuticals, Inc.; UCB Pharma, Inc.

Other: Independent contractor for: Aditum Bio; Almirall Hermal GmbH; AltruBio Inc.; AnaptysBio; Arcutis Inc.; Arena Pharmaceuticals, Inc.; Aristea Therapeutics; Arrive Techonologies; Avotres Therapeutics; BiomX; Boehringer Ingelheim Pharmaceuticals, Inc.; Brickell Biosciences; Corevitas; Dermavant Sciences; Dr. Reddy's Laboratories; Evelo Biosciences; Evommune Inc.; Forte Biosciences; Helsinn Therapeutics, Inc Therapeutics; Hexima Ltd.; Leo Pharma; Meiji Seika Pharma; Mindera; Pfizer Inc.; Seanergy; Verrica

Herve Bachelez, MD, PhD

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; Anaptysbio; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; UCB Pharma, Inc.

Served as a speaker or a member of a speakers bureau for: Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; UCB Pharma, Inc.

Received grants for clinical research from: Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals; LEO Pharma; Pfizer Inc.

Other: Independent contractor for: AbbVie Inc.; Anaptysbio; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; UCB Pharma, Inc.

Siew Eng Choon, FRCP

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation

Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Zuellig Pharma

Other: Independent contractor for: Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; UCB Pharma, Inc.